Predicting AML Chemosensitivity with ARTN and CCL23
In the field of oncology, one of the pressing challenges has always been predicting how patients will respond to chemotherapy. ...
In the field of oncology, one of the pressing challenges has always been predicting how patients will respond to chemotherapy. ...
In a groundbreaking multi-center, real-world study recently published in BMC Cancer, researchers unveil critical insights into the clinical efficacy of ...
In the realm of oncology, the quest for precision medicine has led to intriguing advancements that hold promise for cancer ...
In a groundbreaking study, chemists from the Massachusetts Institute of Technology (MIT) have developed a novel approach to cancer treatment ...
Recent advancements in cancer genomics have unveiled the intricate role that selenoproteins play in hepatic cellular mechanisms, particularly in the ...
Immunotherapy has revolutionized the treatment landscape for lung cancer, yet predicting which patients will benefit from immune checkpoint inhibitors (ICIs) ...
In a groundbreaking advance that promises to transform the landscape of precision oncology, researchers have unveiled an unprecedented multimodal dataset ...
Esophageal adenocarcinoma (EAC) represents one of the most formidable challenges in modern oncology, recognized as the sixth leading cause of ...
In a groundbreaking advancement presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, researchers from Dana-Farber Cancer ...
The role of protein biomarkers in cancer treatment has long fascinated the medical research community, offering a potential pathway toward ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine